Trade name： Giotrif Therap-Cat: Anticancer Originator: Boehringer Ingelheim Indication：the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC) Chemical name：N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2-butenamide CAS#: 850140-72-6 Chemical structure: Intermediates of Afatinib: 162012-67-1 86087‐23‐2 314771-76-1 […]